Table 2.

Effect of group assignment on initiation and completion of human papillomavirus (HPV) vaccination ^a for daughters 11 months after baseline.

	Vaccination initiation or completion				Unadjusted RR (95% CI)	Adjusted b RR (95% CI)
	Yes		No
Among all daughters:
Vaccine completion (3 doses), n (%)
Control group (diabetes education)	8	(28)	21	(72)	1.0	1.0
Intervention group (HPV education)	8	(32)	17	(68)	1.2 (0.6 – 2.3)	1.1 (0.5 – 2.3)
Among daughters who had received no vaccinations c at baseline:
Vaccine initiation (≥1 dose), n (%)
Control group (diabetes education)	6	(27)	16	(73)	1.0	1.0
Intervention group (HPV education)	11	(50)	11	(50)	1.8 (0.8 – 4.4)	2.6 (1.4 – 4.9)
Vaccine completion (3 doses)d
Control group (diabetes education)	-	-	-	-	1.0	1.0
Intervention group (HPV education)	-	-	-	-	3.0 (0.8 – 10.8)	4.0 (1.2 – 13.1)

^aVaccination status was reported by mothers; daughters fully vaccinated at baseline were excluded from analyses;

^bAdjusted for income;

^cNo vaccinations or mother did not know number of vaccinations at baseline;

^dNumbers and percentages are not provided for this comparison due to a cell size <5;

CI = confidence interval.